drugset / Trial / NCT05692037
Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of yttrium-90 carbon microspheres in patients with unresectable colorectal liver metastases
Timeline
- Start
- 2022-12-28
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | yttrium-90 carbon microspheres | Unknown | — | — |
Indications
No indication recorded.